medigraphic.com

2003, Number s1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2003; 41 (s1)

Clinical Guideline for Diagnosis, Treatment, and Prevention of Trichomonas or Candida Caused Cervicovaginitis

Trejo y PJA, Hernández LB, Carrasco RJR, Ducoing DDLR

Language: Spanish
References: 14
Page: 71-76
PDF size: 121.05 Kb.


ABSTRACT

Cervicovaginitis is caused by Candida albicans or Trichomonas vaginalis in 90 % of cases. Once diagnosed, it is important to know its etiology to obtain therapeutic efficacy, given that this illness is associated with increase of morbidity in women of reproductive age. To streamline the process of care, evidence-based practice guidelines were developed. The structure of the guidelines is based on the sequence of daily clinical decisionmaking. It includes recommendations to prevent, diagnose, and treat cervicovaginitis in primarycare facilities. In these guidelines, the importance of combining simple chemical and bacteriologic techniques that can be available in primary-care clinics is highlighted. The guidelines are based on published evidence registered in the Cochrane Library and Medline databases. The search for publications included the period between 1980 and 2002.


REFERENCES

  1. Sobel JD. Bacterial vaginosis. Ann Rev Med 2000; 51:349-356.

  2. Egan ME. Problem-oriented diagnosis. Am Fam Physician 2000;62:1095-1104.

  3. Velasco MV, Pozos CJL, Cardona PJA. Enfermedades infecciosas del cérvix uterino, vagina y vulva: Prevención, diagnóstico y tratamiento. Rev Med IMSS 1999;37(3):185-191.

  4. Joesoef MR, Schmid GP, Hillier SL. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. CID 1999;28 (Suppl): S57-S65.

  5. Lappa S, Coleman MT, Mosciki AN. Managing sexually transmitted diseases in adolescents. Primary Care; Clinics in office practice 1998;25:71-110.

  6. Harmanli OH, Cheng GY, Nyirjesy P, Chatwani A, Caughan JP. Urinary tract infections in women with bacterial vaginosis. Obstet Gynecol 2000;95: 710-712.

  7. Blocklehurst P, Hannah M, McDonald H. Interventions for treating bacterial vaginosis in pregnancy. The Cochrane Database of Systematic Reviews 2002;1.

  8. Centers for Disease Control. 1998 guidelines for treatment of sexually transmitted diseases. MMWR 1998;47(RR-1):1-116.

  9. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.

  10. Krieger, JN, Tam MR, Stevens CE, Nielsen IO, Hale J, Kiviat NV, et al. Diagnosis of Trichomoniasis. Comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 1988;259: 1223-1227.

  11. Carr PL, Felsenstein D, Friedman RH. Evaluation and management of vaginitis. J Gen Intern Med 1988;13:335-346.

  12. Potter J. Should sexual partners of women with bacterial vaginosis receive treatment? Br J Gen Practice 1999;49:913-918.

  13. Watson MC, Grimshaw W, Bond CM, Mollison J, Ludbrook A. Oral versus intravaginal imidazole and triazole antifungal treatment of uncomplicated vulvovaginal candidiasis (thrush). The Cochrane Database of Systematic Reviews 2002;2.

  14. Forna F, Gulmezoglu AM. Interventions for treating trichomoniasis in women. The Cochrane Database of Systematic Review 2002;1.




2020     |     www.medigraphic.com